Literature DB >> 10476940

Interferon-alpha upregulates gene expression of aquaporin-5 in human parotid glands.

J K Smith1, A A Siddiqui, L A Modica, R Dykes, C Simmons, J Schmidt, G A Krishnaswamy, S L Berk.   

Abstract

Aquaporins are a family of homologous membrane proteins that function as highly selective water channels. Aquaporin-5 (AQP5) is uniquely present in lacrimal and salivary glands, where it accounts for normal tear and saliva production. We tested the hypothesis that orally administered human interferon-alpha (HuIFN-alpha) benefits persons with xerostomia by augmenting the production of AQP5 protein by parotid gland epithelium. Cells from three human parotid glands were cultured with and without human lymphoblastoid IFN-alpha, and assayed for AQP5 mRNA levels by reverse transcriptase polymerase chain reaction (RT-PCR), and AQP5 protein levels by Western blot. Intracellular localization of AQP5 protein was done using confocal microscopy. The functional integrity of the glandular tissue was confirmed by RT-PCR analysis of alpha-amylase 1 and basic proline-rich protein transcripts. AQP5 was constitutively expressed in human parotid gland tissue, with AQP5 protein restricted to the plasma membranes and cytoplasmic vesicles of acinar cells. IFN-alpha augmented AQP5 transcription and protein production in a concentration-dependent manner, and increased the size of intensity of staining of AQP5-containing cytoplasmic vesicles in acinar cells. We conclude that IFN-alpha upregulates AQP5 gene expression in human parotid acinar cells in vitro. To our knowledge, this is the first demonstration that IFN-alpha regulates the gene expression of an aquaporin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476940     DOI: 10.1089/107999099313479

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  17 in total

1.  Aquaporin gene expression and regulation in the ovine fetal lung.

Authors:  H Liu; S B Hooper; A Armugam; N Dawson; T Ferraro; K Jeyaseelan; A Thiel; I Koukoulas; E M Wintour
Journal:  J Physiol       Date:  2003-06-20       Impact factor: 5.182

Review 2.  What are aquaporins for?

Authors:  A E Hill; B Shachar-Hill; Y Shachar-Hill
Journal:  J Membr Biol       Date:  2004-01-01       Impact factor: 1.843

3.  Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.

Authors:  Peter Olsson; Iris L A Bodewes; Anna M Nilsson; Carl Turesson; Lennart T H Jacobsson; Elke Theander; Marjan A Versnel; Thomas Mandl
Journal:  Rheumatol Int       Date:  2019-05-28       Impact factor: 2.631

Review 4.  Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.

Authors:  B M Lodde; B J Baum; P P Tak; G Illei
Journal:  Ann Rheum Dis       Date:  2006-07-31       Impact factor: 19.103

5.  AQPs and control of vesicle volume in secretory cells.

Authors:  H Sugiya; M Matsuki
Journal:  J Membr Biol       Date:  2006-07-25       Impact factor: 1.843

6.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

7.  Genetic and environmental factors associated with dental caries in children: the Iowa Fluoride Study.

Authors:  X Wang; M C Willing; M L Marazita; S Wendell; J J Warren; B Broffitt; B Smith; T Busch; A C Lidral; S M Levy
Journal:  Caries Res       Date:  2012-04-13       Impact factor: 4.056

8.  Redefining the Phenotype of Dental Caries.

Authors:  Megan Weber; Jenny Bogstad Søvik; Aida Mulic; Kathleen Deeley; Anne B Tveit; Jessalyn Forella; Nicholas Shirey; Alexandre R Vieira
Journal:  Caries Res       Date:  2018-01-25       Impact factor: 4.056

9.  Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.

Authors:  G Ahmad; W Torben; W Zhang; M Wyatt; A A Siddiqui
Journal:  Parasite Immunol       Date:  2009-03       Impact factor: 2.280

10.  Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine.

Authors:  Gul Ahmad; Weidong Zhang; Workineh Torben; Chad Haskins; Sue Diggs; Zahid Noor; Loc Le; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2009-10-07       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.